State Street Corp Biomea Fusion, Inc. Call Options Transaction History
State Street Corp
- $2.21 Trillion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BMEA
# of Institutions
119Shares Held
25.7MCall Options Held
2.56MPut Options Held
879K-
Cormorant Asset Management, LP Boston, MA3.57MShares$15.8 Million3.07% of portfolio
-
Laurion Capital Management LP New York, NY2.72MShares$12.1 Million0.36% of portfolio
-
Baker Bros. Advisors LP New York, NY2.11MShares$9.34 Million0.4% of portfolio
-
Black Rock Inc. New York, NY1.97MShares$8.74 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.37MShares$6.05 Million0.0% of portfolio
About Biomea Fusion, Inc.
- Ticker BMEA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,290,600
- Market Cap $130M
- Description
- Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...